Invention Grant
US08217062B2 Topical composition comprising a dihydropyridine calcium antagonist
失效
包含二氢吡啶钙拮抗剂的局部组合物
- Patent Title: Topical composition comprising a dihydropyridine calcium antagonist
- Patent Title (中): 包含二氢吡啶钙拮抗剂的局部组合物
-
Application No.: US12439100Application Date: 2007-08-31
-
Publication No.: US08217062B2Publication Date: 2012-07-10
- Inventor: Johan Engblom , Birgitta Svensson , Anette Abrahamsson , Åke Lindahl
- Applicant: Johan Engblom , Birgitta Svensson , Anette Abrahamsson , Åke Lindahl
- Applicant Address: SE Solna
- Assignee: Moberg Derma AB
- Current Assignee: Moberg Derma AB
- Current Assignee Address: SE Solna
- Agency: Manelli Selter PLLC
- Agent Jeffrey S. Melcher
- Priority: SE0601806 20060901
- International Application: PCT/SE2007/000758 WO 20070831
- International Announcement: WO2008/026984 WO 20080306
- Main IPC: C07D211/90
- IPC: C07D211/90

Abstract:
A topical composition comprising a dihydropyridine calcium antagonist, a stiffening agent and a release modifier. The stiffening agent comprises a fatty alcohol, a fatty acid sorbitane ester, or a fatty acid glycerol ester, having a hydrocarbon chain containing 12 to 22 carbon atoms and having a melting point of about 45 to 750° C. The release modifier comprises a fatty alcohol, a fatty alcohol glycol ether, a fatty acid alkyl ester, a fatty acid glycerol ester, or a fatty acid sorbitane ester, having a hydrocarbon chain containing 12 to 18 carbon atoms and having a melting point of about −10 to 400° C. Use of such a composition for the treatment and/or prophylaxis of a dermal or mucosal disorder, preferably an anorectal disorder associated with high anal pressure or anal sphincter spasm.
Public/Granted literature
- US20100010052A1 TOPICAL COMPOSITION COMPRISING A DIHYDROPYRIDINE CALCIUM ANTAGONIST Public/Granted day:2010-01-14
Information query